Helius Medical Technologies is trading 5.2% down today at $1.74 as the stock undergoes a technical pullback following a sharp rebound and ongoing volatility surrounding its strategic shift.
- The company recently announced a rebranding to Solana Company as part of a pivot into a Solana-focused digital asset treasury strategy.
- The move follows a period of intense trading activity sparked by news of large private Solana-linked financing rounds.
- With no fresh filings or analyst calls today, the decline appears to be a correction following the prior session's gains.